Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides)

Regulatory Peptides

Volumn 114, Issue 2-3, 2003, Pages 183-187

  Mikhailova, Augusta ^a   Fonina, Larissa ^a   Kirilina, Elena ^a   Gur'yanov, Sergey ^a   Efremov, Mikhail ^a   Petrov, Rem ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Immune homeostasis; Immunocorrection; Immunoregulatory peptide; Myelopeptide; Target cell

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUORESCEIN ISOTHIOCYANATE; LEUCYLVALYLCYSTEINYLTYROSYLPROLYLGLUTAMINE; LEUCYLVALYLVALYLTYROSYLPROLYLTRYPTOPHAN; MYELOPEPTIDE; PEPTIDE DERIVATIVE; PHENYLALANYLARGINYLPROLYLARGINYLISOLEUCYLMETHIONYLTHREONYLPROLINE; PHENYLALANYLLEUCYLGLYCYLPHENYLALANYLPROLYLTHREONINE; UNCLASSIFIED DRUG; VALYLASPARTYLPROLYLPROLINE; VALYLVALYLTYROSYLPROLYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL POPULATION; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG SYNTHESIS; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALIA;

EID: 0038460884     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00123-X     Document Type: Article

References (14)

1. Goldstein A.L., Slater F.D., White A. Preparation, assay and partial purification of a thymic lymphopoietic factor (thymosin). Proc. Natl. Acad. Sci. U. S. A. 69:1966;1800-1803.
2. Goldstein A.L., Scheld M., Boyel E.A., Schlesinger D.H., Von V.J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science. 204:1979;1309-1310.
3. Goldstein A.L. Thymic hormones and lymphokines. 1984;Plenum, London.
4. Petrov R.V., Mikhailova A.A., Fonina L.A. Myelopeptides: bone marrow regulatory mediators. Biosci. Rep. 15:1995;1-14.
5. Petrov R.V., Mikhailova A.A., Fonina L.A. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity. Biopolym. Pept. Sci., Compr. Rep. Rev. 43(2):1997;139-145.
6. Petrov R.V., Mikhailova A.A., Fonina L.A., Stepanenko R.N. Myelopeptides. 1999;World Scientific, Singapore.
7. Mikhailova A.A., Fonina L.A., Kirilina E.A., Shanurm S.Yu., Gur'yanov S.A., Malakhov A.et al. Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture. Regul. Pept. 53:1994;203-209.
8. Strelkov L.A., Mikhailova A.A., Sapozhnikov A.M., Fonina L.A., Petrov R.V. The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T-lymphocytes. Immunol. Lett. 50:1996;143-147.
9. Belevskaya R.G., Mikhailova A.A., Fonina L.A., Efremov M.A., Petrov R.V. Myelopeptide-3-bone marrow mediator stimulating of the macrophages phagocytosis. Rep. Acad. Sci. (Russia). 358(6):1998;847-849.
10. Strelkov L.A., Mikhailova A.A., Sapozhnikov A.M., Fonina L.A., Petrov R.V. A new endogenous differentiating factor (myelopeptide-4) for myeloid cells. FEBS Lett. 470:2000;281-284.
11. Zolotarev Yu.A., Dorokhova E.M., Nezavibatko V.N., Borisov Yu.A., Rosenberg S.G., Velikodvorskaia G.A.et al. The solid-state catalytic synthesis of tritium labelled amino acids, peptides and proteins. Amino Acids. 8:1995;353-365.
12. Chio J.W., Heil M., Arlin Z., Lutton J.D., Choi Y.S., Leung K. Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor. Proc. Natl. Acad. Sci. U. S. A. 83(10):1986;3432-3436.
13. Rich R.R., Pierce C.W. Biological expression of lymphocyte activation: II. Generation of a population of thymus-derived suppressor lymphocytes. J. Exp. Med. 137:1973;649-659.
14. Petrov R.V., Mikhailova A.A., Kirilina E.A. Myelopeptide-1 blocks the T-suppressor activity. Praha: Folia Biol. 40:1994;455-461.